Establishing COVID-19 testing protocols for your cancer program is critical to safe and effective cancer care. Michelle Shiller, DO, AP/CP, MGP, Co-Medical Director of Genetics, Baylor Sammons Cancer Center, and Staff Pathologist, Baylor University Medical Center, shares an overview of the current landscape of testing access and interpretation, guidance for establishing screening and testing protocols to fit your program.
View On-Demand ReplayDownload Slides

This webcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., and Pfizer, Inc.